Habit cessation device
Latest Patents:
- Composition based on probiotics and uses thereof
- Composition for improving inflammation of brain tissue
- Composition for inhibition of differentiation of osteoclast precursor cells into osteoclasts, and composition for improving bone metabolism
- Pharmaceutical composition for treating myocardial ischemia and preparation method therefor
- Plasmonics-active metal nanostar compositions and methods of use
Description
FIG. 1 is a front plan view of a habit cessation device therein showing our design;
FIG. 2 is a side plan view thereof, the opposite side being a mirror image;
FIG. 3 is a top plan view thereof;
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a perspective view thereof; and,
FIG. 6 is another perspective view of the habit cessation device being opened by a user thereof.
The broken lines are shown for illustrative purposes only and form no part of the claimed design.
The surfaces or portions of the article not shown in the drawing or described in the specification form no part of the claimed design.
Claims
The ornamental design for the habit cessation device, as shown and described.
Referenced Cited
Patent History
Patent number: D440352
Type: Grant
Filed: Dec 1, 1997
Date of Patent: Apr 10, 2001
Assignee: (Dallas, TX)
Inventors: Fred M. Gore (Carrollton, TX), Vesta Brue (Dallas, TX)
Primary Examiner: Alan P. Douglas
Assistant Examiner: Jennifer Rivard
Attorney, Agent or Law Firm: Jenkens & Gilchrist
Application Number: 29/080,096
Type: Grant
Filed: Dec 1, 1997
Date of Patent: Apr 10, 2001
Assignee: (Dallas, TX)
Inventors: Fred M. Gore (Carrollton, TX), Vesta Brue (Dallas, TX)
Primary Examiner: Alan P. Douglas
Assistant Examiner: Jennifer Rivard
Attorney, Agent or Law Firm: Jenkens & Gilchrist
Application Number: 29/080,096
Classifications
Current U.S. Class:
Case Or Receptacle (D27/186);
Fully Enclosed (D27/189)
International Classification: 2706;
International Classification: 2706;